Additional information
| Active substance | Valganciclovir Hydrochloride |
|---|---|
| Water Retention | Unlikely |
| Hepatotoxicity | Low risk but can occur |
| Lab Test | Monitoring of complete blood count and renal function tests are recommended |
| Strength | 450mg |
| Also known as | Valcyte |
| Blood pressure | No direct effects known |
| Trade name | Valcyte |
| Storage conditions | Store at room temperature between 15В°C and 30В°C (59В°F and 86В°F) |
| Chemical name | Valganciclovir hydrochloride |
| Formula | C14H22N6O5 |
| Substance class | Antiviral medication |
| Main action | Inhibits the replication of viral DNA |
| Half-life | 4 hours |
| Dosage (medical) | Typically 900 mg taken orally twice daily for induction therapy, and 900 mg once daily for maintenance therapy |
| Dosage (sports) | Not applicable |
| Effects | Reduction in viral load and improvement in symptoms associated with cytomegalovirus (CMV) infections |
| Side effects | Diarrhea, neutropenia, fever, anemia, leukopenia, and potential retinal detachment |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 4 tabs/blister |
GLUCOPHAGE Merckgroup
Muscoflex 8 mg Bilim
Norvacs 5 mg Pfizer
Januvia 100mg Merckgroup
Champix 56 tabs Pfizer
Champix Starter Pack Pfizer
Prograf 5mg Astellas Pharma
Rovamycine 3.000.000 iu Eczacibasi
Avory Pharma Deca Durabolin 300mg 10ml 


Reviews
There are no reviews yet.